Recent progress in lactate oxidase-based drug delivery systems for enhanced cancer therapy
Nanoscale · 2024 · 16 (18) · 8739-8758
DOI: 10.1039/d3nr05952a ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale, 2024. Verfasst von Lu Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, Sichuan, China. yw@swjtu.edu.cn. Hauptthemen laut MEDLINE: Neoplasms, Mixed Function Oxygenases, Drug Delivery Systems. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Classification of LOX-based DDSs for tumour therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, Sichuan, China. yw@swjtu.edu.cn.
- College of Medicine, Southwest Jiaotong University, Chengdu 610031, Sichuan, China.
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Li, L., Yue, T., Feng, J., Zhang, Y., Hou, J., & Wang, Y. (2024). Recent progress in lactate oxidase-based drug delivery systems for enhanced cancer therapy. Nanoscale, 16(18), 8739-8758. https://doi.org/10.1039/d3nr05952a
Vancouver
Li L, Yue T, Feng J, Zhang Y, Hou J, Wang Y. Recent progress in lactate oxidase-based drug delivery systems for enhanced cancer therapy. Nanoscale. 2024;16(18):8739-8758. doi:10.1039/d3nr05952a
BibTeX
@article{Li2024,
author = {Li, Lu and Yue, Tian and Feng, Jie and Zhang, Yujun and Hou, Jun and Wang, Yi},
title = {Recent progress in lactate oxidase-based drug delivery systems for enhanced cancer therapy},
journal = {Nanoscale},
year = {2024},
volume = {16},
number = {18},
pages = {8739--8758},
doi = {10.1039/d3nr05952a}
}
EUVIMED